18Jan2022 Read more FDA warns of dental problems associated with certain buprenorphine medications FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.
10Jan2022 Read more New HIV PrEP guidelines call for clinicians to talk with patients about prevention meds CDC now advises all clinicians to talk to their patients who are sexually active, including adolescents, about HIV preexposure prophylaxis (PrEP) at least once and to prescribe the prevention medication to anyone who requests them.
17Dec2021 Read more Study links statins with more aggressive diabetes progression Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in JAMA Internal Medicine.
13Dec2021 Read more FDA puts clozapine REMS requirements on temporary hold FDA said it is temporarily halting its risk evaluation and mitigation strategy (REMS) program for clozapine, a treatment for schizophrenia.